Table 1.
Comparison of the baseline clinical variables between the non-pimobendan and pimobendan treatment groups
| Variable | Non-pimobendan group Median (range) | Pimobendan group Median (range) | P value |
|---|---|---|---|
| LVIDs | 17.55 (14.0–22.4) | 17.6 (14.3–26) | 0.48 |
| LVIDd | 20.65 (15.6–25.7) | 22.15 (17.7–28.5) | 0.26 |
| IVSd | 3.4 (2.5–5.7) | 4.15 (2.7–5.4) | 0.19 |
| LVFWd | 4.6 (2.6–6.2) | 4.5 (1.9–5.4) | 0.33 |
| FS | 14.35 (3–26) | 16.9 (7–27) | 0.23 |
| LA | 20.4 (11–27.5) | 24.3 (15–31.4) | 0.038* |
| LA/AO | 2.77 (1.6–3.35) | 3.21 (2.24–5.24) | 0.007* |
| ATE | 2 | 1 | 0.61 |
| Heart rate | 180 (116–200) | 200 (120–250) | 0.17 |
| Temperature | 37.6 (34.1–39.8) | 37.7 (33–39.3) | 0.56 |
| Bodyweight | 4.38 (2.8–6.44) | 4.83 (3.4–7.75) | 0.36 |
| Age | 10 (4–15) | 10 (3–18) | 0.72 |
| Female | 7 | 4 | 0.30 |
| Male | 9 | 12 | 0.30 |
| Valvular insufficiency | 8 | 14 | 0.03* |
| Gallop | 14 | 9 | 0.06 |
*
Denotes P values <0.05
LVIDs = left ventricular internal dimension at end systole, LVIDd = left ventricular internal dimension at end diastole, IVSd = interventricular septal thickness at end diastole, LVFWd = left ventricular free wall thickness at end diastole, FS = fractional shortening, LA = left atrial dimension, AO = aortic outflow, ATE = aortic thromboembolism